Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Long-Term Deferred Tax: 2022-2024

Historic Long-Term Deferred Tax for Kiniksa Pharmaceuticals International (KNSA) over the last 3 years, with Dec 2024 value amounting to $211.2 million.

  • Kiniksa Pharmaceuticals International's Long-Term Deferred Tax fell 3.22% to $201.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $201.3 million, marking a year-over-year decrease of 3.22%. This contributed to the annual value of $211.2 million for FY2024, which is 3.71% down from last year.
  • Per Kiniksa Pharmaceuticals International's latest filing, its Long-Term Deferred Tax stood at $211.2 million for FY2024, which was down 3.71% from $219.3 million recorded in FY2023.
  • Kiniksa Pharmaceuticals International's 5-year Long-Term Deferred Tax high stood at $219.3 million for FY2023, and its period low was $185.5 million during FY2022.
  • In the last 3 years, Kiniksa Pharmaceuticals International's Long-Term Deferred Tax had a median value of $211.2 million in 2024 and averaged $205.3 million.
  • As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Long-Term Deferred Tax grew by 18.22% in 2023, and later decreased by 3.71% in 2024.
  • Kiniksa Pharmaceuticals International's Long-Term Deferred Tax (MRY) stood at $185.5 million in 2022, then rose by 18.22% to $219.3 million in 2023, then fell by 3.71% to $211.2 million in 2024.
  • Its Long-Term Deferred Tax stands at $211.2 million for FY2024, versus $219.3 million for FY2023 and $185.5 million for FY2022.